Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 45

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 45
---
 that could adversely affect  
 investors who purchase in the offering.                                                                                                |

| · | To close a covered position, the underwriters must purchase shares in the                                                                     
 open market after the distribution has been completed or must exercise the option to purchase additional shares. In determining the source    
 of shares to close the covered short position, the underwriters will consider, among other things, the price of shares available for purchase 
 in the open market as compared to the price at which they may purchase shares through the option to purchase additional shares.               |

| · | Stabilizing transactions involve bids to purchase shares so long as the stabilizing 
 bids do not exceed a specified maximum.                                             |

Purchases to cover short positions and transactions
that have the effect of stabilizing purchases, as well as other purchases by the underwriters for their own accounts, may have the effect
of preventing or retarding a decline in the market price of the shares of Series B Preferred Stock. They may also cause the price
of the shares to be higher than the price that would otherwise exist in the open market in the absence of these transactions. The underwriters
may conduct these transactions on the NYSE, in the over-the-counter market or otherwise. If the underwriters commence any of these transactions,
they may discontinue them at any time.

<div align='center'>S-26</div>

No Sales of Similar Securities

For a period beginning on the date of this prospectus
and through 30 days after the date of this prospectus, we have agreed that we will not, without the prior written consent of the Representatives,
(i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Series B Preferred
Stock or any other shares of our preferred stock ranking on parity with or senior to the Series B Preferred Stock or any securities
convertible into or exercisable or exchangeable into shares thereof or file any registration statement under the Securities Act with respect
to any of the foregoing, (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part,
directly or indirectly, the economic consequence of ownership of the Series B Preferred Stock (iii) establish or increase a
put equivalent position or liquidate or decrease a call equivalent position in the Series B Preferred Stock within the meaning of
Section 16 of the Exchange Act